NO920983L - PROCEDURE FOR THE TREATMENT OF NEVRODEGENERATIVE CONDITIONS - Google Patents

PROCEDURE FOR THE TREATMENT OF NEVRODEGENERATIVE CONDITIONS

Info

Publication number
NO920983L
NO920983L NO92920983A NO920983A NO920983L NO 920983 L NO920983 L NO 920983L NO 92920983 A NO92920983 A NO 92920983A NO 920983 A NO920983 A NO 920983A NO 920983 L NO920983 L NO 920983L
Authority
NO
Norway
Prior art keywords
nevrodegenerative
procedure
treatment
conditions
nevrodegenerative conditions
Prior art date
Application number
NO92920983A
Other languages
Norwegian (no)
Other versions
NO920983D0 (en
Inventor
Paul Jerome Marangos
Harry Edward Gruber
Original Assignee
Gensia Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gensia Pharma filed Critical Gensia Pharma
Publication of NO920983D0 publication Critical patent/NO920983D0/en
Publication of NO920983L publication Critical patent/NO920983L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatment Of Fiber Materials (AREA)
NO92920983A 1989-09-15 1992-03-13 PROCEDURE FOR THE TREATMENT OF NEVRODEGENERATIVE CONDITIONS NO920983L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40791389A 1989-09-15 1989-09-15
PCT/US1990/005180 WO1991004032A1 (en) 1989-09-15 1990-09-12 Methods of treating neurodegenerative conditions

Publications (2)

Publication Number Publication Date
NO920983D0 NO920983D0 (en) 1992-03-13
NO920983L true NO920983L (en) 1992-03-13

Family

ID=23614067

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92920983A NO920983L (en) 1989-09-15 1992-03-13 PROCEDURE FOR THE TREATMENT OF NEVRODEGENERATIVE CONDITIONS

Country Status (6)

Country Link
EP (1) EP0491792A4 (en)
JP (1) JPH05506842A (en)
KR (1) KR920703068A (en)
AU (1) AU643235B2 (en)
NO (1) NO920983L (en)
WO (1) WO1991004032A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69232121T2 (en) * 1991-08-09 2002-06-20 Massachusetts Inst Technology USES OF A PROTEIN KINASE OF CLAY AND NEUROFILAMENT PK40
DK62592D0 (en) * 1992-05-14 1992-05-14 Novo Nordisk As
EP0582164B1 (en) * 1992-07-31 1998-12-23 Bristol-Myers Squibb Company Adenosine re-uptake inhibiting derivatives of diphenyl oxazoles, thiazoles and imidazoles
US5589467A (en) * 1993-09-17 1996-12-31 Novo Nordisk A/S 2,5',N6-trisubstituted adenosine derivatives
US5780450A (en) * 1995-11-21 1998-07-14 Alcon Laboratories, Inc. Use of adenosine uptake inhibitors for treating retinal or optic nerve head damage
DE19707655A1 (en) * 1997-02-26 1998-08-27 Hoechst Ag Combination preparation for use in dementia
US6440455B1 (en) * 1997-09-02 2002-08-27 Children's Medical Center Corporation Methods for modulating the axonal outgrowth of central nervous system neurons

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4575498A (en) * 1983-07-21 1986-03-11 Duke University Method for restoring depleted purine nucleotide pools
US4912092A (en) * 1986-03-27 1990-03-27 The Regents Of The University Of California Methods for increasing extracellular adenosine and for stabilizing mast cells

Also Published As

Publication number Publication date
JPH05506842A (en) 1993-10-07
AU643235B2 (en) 1993-11-11
EP0491792A4 (en) 1992-12-02
WO1991004032A1 (en) 1991-04-04
NO920983D0 (en) 1992-03-13
EP0491792A1 (en) 1992-07-01
KR920703068A (en) 1992-12-17
AU6401590A (en) 1991-04-18

Similar Documents

Publication Publication Date Title
NO934304L (en) Procedure for the treatment of fluoroalumosilicate glass
NO173498C (en) Analogous procedure for the preparation of substituted 9-amino-tetrahydroacridines
NO902003D0 (en) PROCEDURE FOR THE PREPARATION OF N-HETEROARYL-4-QUINOLINAMINES.
NO901554D0 (en) PROCEDURE FOR THE PREPARATION OF DINATE-CEFODIZIM.
NO921962D0 (en) PROCEDURE FOR THE PREPARATION OF SULFAT PREPARATION
NO171974C (en) PROCEDURE FOR THE MANUFACTURING OF NIGHT-MAINTENANCE DERIVATIVES
NO930574L (en) Procedure for the preparation of desfluran
NO921993D0 (en) PROCEDURE FOR THE TREATMENT OF AMPOTAIR OR SWITTERIONIC TENSIDES
NO920983D0 (en) PROCEDURE FOR THE TREATMENT OF NEVRODEGENERATIVE CONDITIONS
NO913117L (en) PROCEDURE FOR THE TREATMENT OF NECESSARY DISEASES.
NO893890L (en) PROCEDURE FOR THE REMOVAL OF SULPHIDS.
NO901067L (en) PROCEDURE FOR THE PREPARATION OF TIOPHENES.
NO171373C (en) PROCEDURE FOR THE MANUFACTURE OF BISCAR BAMBATES
NO900969L (en) PROCEDURE FOR THE PREPARATION OF N-ALLYMETATE TRIFLUORMETHYLANILINE.
NO901422L (en) PROCEDURE FOR THE PREPARATION OF ALFA-GLUCOSIDASE INHIBITORS.
NO903397D0 (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY EFFECTIVE DERIVATIVES OF PROTOCATECHUALDEHYD.
NO884635D0 (en) PROCEDURE FOR TREATMENT OF MUST.
FI943660A0 (en) Process for the preparation of 3-carbonylandrostadiene-17-carboxamides
NO920694L (en) PROCEDURE FOR TREATMENT OF TREMASS
KR890701106A (en) Use of oxoquinazoline derivatives for the treatment of hyperlipidemia
NO174196C (en) Process for the preparation of omega-decenol
NO171565C (en) PROCEDURE FOR TREATMENT OF MANGANSLAM
NO904070D0 (en) PROCEDURE FOR THE PREPARATION OF ALKANPHENONES.
NO902968D0 (en) PROCEDURE FOR TREATMENT OF BORESLAM.
NO930481L (en) PROCEDURE FOR THE PREPARATION OF CHLORMETHANE